. northern ireland's top 100 companies for 2018 revealed .
.
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
cutting luxuries could give savers extra ?10k in retirement.